Collegium Pharmaceutical
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.About COLL
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic.
CEOJoseph J. Ciaffoni
CEOJoseph J. Ciaffoni
Employees197
Employees197
HeadquartersStoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded2002
Founded2002
Employees197
Employees197
COLL Key Statistics
Market cap1.20B
Market cap1.20B
Price-Earnings ratio29.00
Price-Earnings ratio29.00
Dividend yield—
Dividend yield—
Average volume352.51K
Average volume352.51K
High today$38.16
High today$38.16
Low today$37.18
Low today$37.18
Open price$38.16
Open price$38.16
Volume294.82K
Volume294.82K
52 Week high$40.95
52 Week high$40.95
52 Week low$20.83
52 Week low$20.83
COLL News
Yahoo Finance 18h
Collegium Pharmaceutical Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo FinanceWall Street expects a year-over-year increase in earnings on higher revenues when Collegium Pharmaceutical (COLL) reports results for the quarter ended March 20...
TipRanks 4d
Collegium Pharmaceutical authorizes generic agreement with HikmaCollegium Pharmaceutical (COLL) announced it has entered into an authorized generic agreement with Hikma Pharmaceuticals (HKMPF), pursuant to which Hikma will h...
Simply Wall St 5d
Can Collegium Pharmaceutical, Inc. Maintain Its Strong Returns? - Simply Wall StOne of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity...
Analyst ratings
67%
of 6 ratingsBuy
66.7%
Hold
33.3%
Sell
0%